BM-131246
BM-131246 is an oral antidiabetic agent.
Product Specifications
CAS Number
[103787-97-9]
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/BM-131246.html
Solubility
10 mM in DMSO
Smiles
O=C(N1)SC(CC2=CC=C(OCCC3=C(C)OC(C4=CC=CC=C4)=N3)C=C2)C1=O
Molecular Formula
C22H20N2O4S
Molecular Weight
408.47
References & Citations
[1]Heitzmann T, et al. Dose proportionality studies of novel thiazolidinedione derivatives as potent antidiabetic agents in mice. Arzneimittelforschung. 1995 Dec;45 (12) :1284-8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1044917-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O157:H7 Lipid-A-disaccharide synthase (lpxB)
Ask
View Details MBS1044917-02 0.02 mg (Yeast)
Recombinant Escherichia coli O157:H7 Lipid-A-disaccharide synthase (lpxB)
Ask
View Details 
MBS1044917-03 0.1 mg (E-Coli)
Recombinant Escherichia coli O157:H7 Lipid-A-disaccharide synthase (lpxB)
Ask
View Details MBS1044917-04 0.1 mg (Yeast)
Recombinant Escherichia coli O157:H7 Lipid-A-disaccharide synthase (lpxB)
Ask
View Details 
MBS1044917-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli O157:H7 Lipid-A-disaccharide synthase (lpxB)
Ask
View Details MBS1044917-06 0.02 mg (Mammalian-Cell)
Recombinant Escherichia coli O157:H7 Lipid-A-disaccharide synthase (lpxB)
Ask
View Details